vs
Side-by-side financial comparison of Laser Photonics Corp (LASE) and Lucid Diagnostics Inc. (LUCD). Click either name above to swap in a different company.
Lucid Diagnostics Inc. is the larger business by last-quarter revenue ($1.2M vs $919.3K, roughly 1.3× Laser Photonics Corp). Laser Photonics Corp runs the higher net margin — -506.4% vs -858.5%, a 352.1% gap on every dollar of revenue. On growth, Laser Photonics Corp posted the faster year-over-year revenue change (28.3% vs 3.3%). Over the past eight quarters, Lucid Diagnostics Inc.'s revenue compounded faster (7.9% CAGR vs -3.9%).
IPG Photonics Corporation is a manufacturer of fiber lasers. IPG Photonics developed and commercialized optical fiber lasers, which are used in a variety of applications including materials processing, medical applications and telecommunications. IPG has manufacturing facilities in the United States, Germany, Russia and Italy.
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics firm focused on non-invasive screening tests for upper gastrointestinal diseases, including early detection of esophageal cancer and pre-cancerous lesions. It mainly serves healthcare providers and clinical partners across the United States, targeting at-risk patient populations.
LASE vs LUCD — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $919.3K | $1.2M |
| Net Profit | $-4.7M | $-10.4M |
| Gross Margin | -20.1% | — |
| Operating Margin | -350.0% | -971.0% |
| Net Margin | -506.4% | -858.5% |
| Revenue YoY | 28.3% | 3.3% |
| Net Profit YoY | -186.5% | 16.0% |
| EPS (diluted) | $-0.27 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $919.3K | $1.2M | ||
| Q2 25 | $2.6M | $1.2M | ||
| Q1 25 | $2.3M | $828.0K | ||
| Q4 24 | $1.3M | $1.2M | ||
| Q3 24 | $716.7K | $1.2M | ||
| Q2 24 | $623.4K | $976.0K | ||
| Q1 24 | $743.0K | $1.0M | ||
| Q4 23 | $994.6K | $1.0M |
| Q3 25 | $-4.7M | $-10.4M | ||
| Q2 25 | $-1.8M | $-4.4M | ||
| Q1 25 | $-1.7M | $-26.9M | ||
| Q4 24 | $586.4K | $-11.5M | ||
| Q3 24 | $-1.6M | $-12.4M | ||
| Q2 24 | $-934.3K | $-11.0M | ||
| Q1 24 | $-545.7K | $-10.6M | ||
| Q4 23 | $-486.6K | $-10.8M |
| Q3 25 | -20.1% | — | ||
| Q2 25 | 53.5% | — | ||
| Q1 25 | 49.8% | — | ||
| Q4 24 | 13.3% | — | ||
| Q3 24 | 85.0% | — | ||
| Q2 24 | 50.6% | — | ||
| Q1 24 | 51.9% | — | ||
| Q4 23 | 84.5% | — |
| Q3 25 | -350.0% | -971.0% | ||
| Q2 25 | -37.0% | -978.8% | ||
| Q1 25 | -68.7% | -1508.1% | ||
| Q4 24 | -255.1% | -1033.8% | ||
| Q3 24 | -238.0% | -997.8% | ||
| Q2 24 | -149.4% | -1146.7% | ||
| Q1 24 | -73.8% | -1078.1% | ||
| Q4 23 | -88.4% | -1101.3% |
| Q3 25 | -506.4% | -858.5% | ||
| Q2 25 | -68.3% | -381.7% | ||
| Q1 25 | -73.4% | -3249.8% | ||
| Q4 24 | 45.7% | -964.2% | ||
| Q3 24 | -226.8% | -1055.5% | ||
| Q2 24 | -149.9% | -1127.6% | ||
| Q1 24 | -73.4% | -1060.1% | ||
| Q4 23 | -48.9% | -1041.3% |
| Q3 25 | $-0.27 | $-0.10 | ||
| Q2 25 | $-0.12 | $-0.08 | ||
| Q1 25 | $-0.12 | $-0.52 | ||
| Q4 24 | $0.06 | $-0.17 | ||
| Q3 24 | $-0.13 | $-0.25 | ||
| Q2 24 | $-0.09 | $-0.23 | ||
| Q1 24 | $-0.06 | $-0.40 | ||
| Q4 23 | $-0.03 | $-0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.6M | $47.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.1M | $25.8M |
| Total Assets | $17.5M | $53.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $3.6M | $47.3M | ||
| Q2 25 | $78.5K | $31.1M | ||
| Q1 25 | $179.1K | $25.2M | ||
| Q4 24 | $533.9K | $22.4M | ||
| Q3 24 | $2.1M | $14.5M | ||
| Q2 24 | $2.7M | $24.9M | ||
| Q1 24 | $5.2M | $24.8M | ||
| Q4 23 | $6.2M | $18.9M |
| Q3 25 | $4.1M | $25.8M | ||
| Q2 25 | $4.3M | $7.9M | ||
| Q1 25 | $6.8M | $-5.4M | ||
| Q4 24 | $10.2M | $5.4M | ||
| Q3 24 | $9.7M | $6.3M | ||
| Q2 24 | $10.3M | $16.0M | ||
| Q1 24 | $12.4M | $11.9M | ||
| Q4 23 | $13.9M | $-2.3M |
| Q3 25 | $17.5M | $53.2M | ||
| Q2 25 | $14.9M | $38.7M | ||
| Q1 25 | $16.0M | $32.8M | ||
| Q4 24 | $17.2M | $30.7M | ||
| Q3 24 | $10.6M | $22.6M | ||
| Q2 24 | $11.1M | $34.1M | ||
| Q1 24 | $13.6M | $32.0M | ||
| Q4 23 | $15.1M | $27.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $763.1K | $-10.9M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $763.1K | $-10.9M | ||
| Q2 25 | $-1.0M | $-10.5M | ||
| Q1 25 | $-1.2M | $-12.5M | ||
| Q4 24 | $-6.5M | $-9.9M | ||
| Q3 24 | $632.7K | $-10.2M | ||
| Q2 24 | $-2.4M | $-11.5M | ||
| Q1 24 | $-866.3K | $-12.6M | ||
| Q4 23 | $-2.0M | $-10.0M |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $589.6K | — | ||
| Q2 24 | $-2.4M | — | ||
| Q1 24 | $-1.0M | — | ||
| Q4 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 82.3% | — | ||
| Q2 24 | -388.0% | — | ||
| Q1 24 | -136.9% | — | ||
| Q4 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 6.0% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 20.3% | — | ||
| Q4 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -11.11× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
